2020
DOI: 10.1016/j.gene.2019.144136
|View full text |Cite
|
Sign up to set email alerts
|

MicroRNA-183-3p up-regulated by vagus nerve stimulation mitigates chronic systolic heart failure via the reduction of BNIP3L-mediated autophagy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 45 publications
0
5
0
Order By: Relevance
“…On the other hand, diversified studies have shown that VNS affects disease progression by regulating the expression of miRs. For instance, VNS treatment alleviates chronic systolic heart failure by upregulating miRNA-183-3p [26]. According to the above studies, VNS represses the release of cytokines by inflammatory cells in epilepsy, so as to inhibit the progression of epilepsy.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, diversified studies have shown that VNS affects disease progression by regulating the expression of miRs. For instance, VNS treatment alleviates chronic systolic heart failure by upregulating miRNA-183-3p [26]. According to the above studies, VNS represses the release of cytokines by inflammatory cells in epilepsy, so as to inhibit the progression of epilepsy.…”
Section: Discussionmentioning
confidence: 99%
“…BNIP3L [62], HBA2 [63], SNCA (synuclein alpha) [64], NAT2 [65] and DAO (D-amino acid oxidase) [66] have been reported to have a crucial role in CNS disorders, but these genes might be involved in the progression of COVID-19. Ouyang et al [67], Vendrov et al [68], Alikhah et al [69], Khelil et al [70] and Xia et al [71] found that BNIP3L, NOX4, SOCS1, NAT2, MYOCD (myocardin) and expression were altered in cardiovascular diseases, but these genes might be involved in the progression of COVID-19. HBA2 [72], NOX4 [73], NAT2 [74] and MYOCD (myocardin) [75] are important in the development of hypertension, but these genes might be involved in the progression of COVID-19.…”
Section: Discussionmentioning
confidence: 99%
“…MiR-183-3p has been shown to discriminate non-HF-controls from patients with HFrEF but also HFpEF ( 34 ). Moreover, miR-183-3p has been found to be down-regulated in rats with chronic systolic HF and it was shown that treatment of these rats with vagus nerve stimulation resulted in an up-regulation of miR-183-3p along with lower NT-proBNP levels ( 35 ). In that study, Bcl-2 interacting protein 3 like was identified as the target gene of miR-183-3p.…”
Section: Discussionmentioning
confidence: 99%